Physician profile
Eric P Muhm
NPI 1932462306
$3,865.74
in general payments reported to CMS, 2019-2025
11 companies · $326 in 2025
The $326 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $355 · 2021: $531 · 2022: $1,435 · 2023: $326 · 2024: $464 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,411.73 | 2019-2025 | Variax, Prostep, Ortholoc 3di |
| Wardlow Enterprises | $1,200.00 | 2022 | |
| Trilliant Surgical LLC. | $839.54 | 2020-2021 | |
| Organogenesis INC. | $139.12 | 2022-2025 | Via Matrix, Puraply |
| Depuy Synthes Sales INC. | $104.10 | 2024 | Motoband, Fibergraft Aeridyan Matrix |
| Convatec INC. | $48.99 | 2024-2025 | |
| Mimedx Group, INC. | $37.69 | 2024 | |
| Kerecis Limited | $28.69 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Novo Nordisk INC | $21.34 | 2021 | |
| Endo Pharmaceuticals INC. | $18.53 | 2019 | |
| Tactile Systems Technology INC | $16.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Muhm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.